Consensus Elevance Health, Inc.

Equities

ELV

US0367521038

Real-time Estimate Cboe BZX Other stock markets 12:46:14 2024-04-24 pm EDT			5-day change	1st Jan Change
530.1 ^USD	-0.53%		+4.11%	+12.37%

03:30pm	Mizuho Adjusts Price Target on Elevance Health to $585 From $575	MT
Apr. 23	TD Cowen Adjusts Elevance Health's Price Target to $624 From $555	MT

Evolution of the average Target Price on Elevance Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0e1d05d.xjgKCLzxBZw1ZEgTmjKmL-1d4P4eGVHrKZx8DmCZrvk.v0BOecuIPKx5DTFS3V3Bad8kk8kqKxy5HMYLS1HR_Y6LdmI-36VO3gEyeA~b446cd9df1236d2b3f27c5240e60299c

Analyst Recommendations on Elevance Health, Inc.

Mizuho Adjusts Price Target on Elevance Health to $585 From $575	09:30am	MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555	Apr. 23	MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating	Apr. 19	MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629	Apr. 19	MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565	Apr. 19	MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602	Apr. 19	MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578	Apr. 19	MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating	Apr. 19	MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating	Apr. 19	MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating	Apr. 19	MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating	Apr. 19	MT
Cantor Fitzgerald Raises Elevance Health Price Target to $600 from $580	Apr. 18	MT
Stephens Adjusts Elevance Health's Price Target to $615 From $580	Apr. 18	MT
Elevance Health 1Q Revenue Rises, Membership Keeps Declining; Raises Guidance	Apr. 18	DJ
Zacks Investment Research Adjusts Price Target on Elevance Health to $523 From $537	Apr. 15	MT
Wells Fargo Cuts Price Target on Elevance Health to $557 From $561, Maintains Overweight Rating	Apr. 08	MT
Barclays Starts Elevance Health With Overweight Rating, $584 Price Target	Mar. 06	MT
Cantor Fitzgerald Adjusts Price Target on Elevance Health to $580 From $547, Maintains Overweight Rating	Feb. 14	MT
US proposes reimbursement rate for Medicare Advantage 2025 payments	Jan. 31	RE
RBC Raises Price Target on Elevance Health to $574 From $572 Amid 'Solid End to 2023,' Keeps Outperform Rating	Jan. 25	MT
JPMorgan Cuts Price Target on Elevance Health to $552 From $569, Maintains Overweight Rating	Nov. 17	MT
Investors see life through rose-colored glasses	Nov. 17
ANALYST RECOMMENDATIONS : Air Products & Chemicals, Barclays, Glencore, Mastercard, Walmart...	Nov. 17
Central bank bonanza!	23-10-30
ANALYST RECOMMENDATIONS : AbbVie, AMD, Astrazeneca, HSBC, Live Nation...	23-10-30

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

532.9 USD

Average target price

599.5 USD

Spread / Average Target

+12.49%

High Price Target

665 USD

Spread / Highest target

+24.78%

Low Price Target

520 USD

Spread / Lowest Target

-2.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Elevance Health, Inc.

TD Cowen
UBS
Bernstein
Leerink Partners
Jefferies & Co.
Goldman Sachs
RBC Capital Markets
Truist Securities
Wells Fargo Securities
Barclays
Cantor Fitzgerald
Stephens Inc.
Zacks Investment Research
JPMorgan Chase
Nephron Research
Morgan Stanley
Deutsche Bank Securities
Wolfe Research
Loop Capital
Morningstar
SVB Securities LLC
Credit Suisse
Mizuho Securities
BofA Securities
Cowen
SVB Leerink
Argus
BMO Capital
Seaport Global Securities

Ratings for Elevance Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar